icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Paris France
11-15 April 2018
Back grey_arrow_rt.gif
 
 
 
Safety, Tolerability, and Pharmacokinetics of BMS-986263/ND-L02-s0201, A Novel Targeted Lipid Nanoparticle Delivering HSP47 siRNA, in Healthy Participants: A Randomised, Placebo-Controlled, Double-Blind, Phase 1 Study
 
 
  Reported by Jules Levin
EASL 2018 April 11-15 Paris France
 
Benjamin Soule, Giridhar S. Tirucherai, Uma Kavita, Sudeep Kundu, Rose Christian Bristol-Myers Squibb, Princeton, NJ, USA

0425181

0425182

0425183

0425184

0425185